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1.1 Aim of the work 
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1.2 Dissertation Outline 
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2. Background in Magnetic Resonance Imaging 
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2.2 Relaxation Processes and the Bloch Equations 
 









2.2.2 Transverse Relaxation (T2) 




























2.3 Chemical Shift 
 𝑣0
ω 𝛾
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𝐵 =  𝐵0(1 − 𝜎) 
σ σ
𝑣 =  (
𝛾
2𝜋








2.4 Spin–Spin Coupling 




Fig 1 Spin-spin interactions involved with scalar coupling. (A) In isolated atoms, the Fermi 
contact energetically favors an antiparallel orientation between nuclear and electronic spins. 
(B) In chemical bonds, the Pauli Exclusion Principle demands that the electron spins are in an 
antiparallel orientation thereby potentially forcing nuclear and electron spins in an 
energetically higher parallel orientation, depending on the nuclear spin state [14]. 
 




2.5 B1 Inhomogeneity and Mapping B1 transmit fields  
Fig 2 Spin Spin coupling  in ,1,2-trichloroethane during 1H MR Spectroscopy [24]. 





1.6.1 Double Angle (ratio method) 
α α
 
𝑀𝑥𝑦1 =  𝑀0 sin(𝛼) 
 























2.6 Alternative Nuclei 
2.6.1 Phosphorous 31 
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Metabolite  Chemical Shift (ppm) 
Adenosine monophosphate (AMP)  6.33 
Adenosine diphosphate (ADP) α -7.05 
 β -3.09 
Adenosine triphosphate (ATP) α -7.52 
 β -16.26 
Fig 3 Typical localized in vivo 31P NMR spectra from (A) rat skeletal muscle, (B) brain and (C) liver. 
Note the complete absence of PCr in the liver [14]. 
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 γ -2.48 
Dihydroxyacetone phosphate  7.56 
Fructuose-6-phosphate  6.64 
Glucose-1-phosphate  5.15 
Glucose-6-phosphate  7.20 
Glycerol-1-phosphate  7.02 
Glycerol-3-phosphorylcoline  2.76 
Glycerol-3-phosphorylcethanolamine  3.20 
Phosphomonoester (PME)  6.90 
Phosphodiester (PDE)  2.20 
Inorganic Phosphate  5.02 
Phosphocreatine  0.00 
Phosphoenolpyruvate  2.06 
Phosphorylcoline  5.88 
Phosphorylethanolamine  6.78 
Nicotinamide adenine dinucleotide (NADH)  -8.30 
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3. Animal Models of Liver Fibrosis 
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3.1 In-Vivo Study 
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Fig 4 A typical Sprague-Dawley albino laboratory rat [41] 
  
 17 | A  3 1 P  M R  S p e c t r o s c o p y  S t u d y  o n  R a t  M o d e l s  o f  L i v e r  D i s e a s e  
 
4. MR Setup 
 
4.1 The MRI apparatus  
 
4.2 Magnet and Gradient 
 
4.3 RF Coil 











 Fig 5 Doty Scientific Doty30 





Fig 6 Remote Coil Matching Units, for both Proton and Phosphorous, from left to right. 
These units were used to manually adjust both matching and tuning on each coil, without 
the need to access it directly. 
Fig 7 Rearside view of the magnet hole and a schematic of Varian’s High Band RF pre amplifier. 
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4.3.1 Tuning and Matching 
Fig 8 Tune Interface Box and Re-Routing Unit representations, from left to right. The Tune Interface Box 
was used to check the tuning for each nuclei, the lower the value on the display, the better. The Re-
Routing Unit was used to link the coil to the Preamplifier while connecting it to the Tuner. 
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4.4 In Vivo specific hardware 
 
Fig 9  SA Instruments Inc. (SAII) Model 1025 MR-compatible monitoring and gating system. 
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5. MR Spectroscopy Sequences 
 
5.1 Image Selected In Vivo Spectroscopy (ISIS) 
 
 
Fig 10 ISIS pulse program, as seen in vNMRj 





Fig 11 Pulse sequence for ISIS localization. For 1D ISIS localization, two experiments are required, one with 
and one without a spatially selective inversion pulse prior to excitation. Subtraction of the two datasets 
will only give signal from the localized volume. For 3D localization, eight experiments (2 × 2 × 2) are 
required as shown, whereby the right column indicates the relative receiver phase (+ = 0◦, − = 180°) [14] 
 
 




Fig 12 Experimental evaluation of 2D ISIS localization by MRI. (A) Image representation of a water-filled 
sphere. No spatially selective (in-plane) inversion pulses were executed. (B and C) Images (in absolute value) 
in which one spatially selective inversion pulse has been executed. The + and− signs correspond to 
noninverted and inverted areas, respectively. (D) Image of the sphere after the execution of two spatially 
orthogonal selective inversion pulses. Due to the double inversion in the middle of the sphere, the 
magnetization resides along the positive longitudinal axis. (E) The localized volume is obtained according to 
the following add–subtract scheme : (E) = (A) − (B) − (C) + (D). 
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5.2 Single Pulse and 1D acquire (SPULS) 
 
Fig 13 SPULS pulse program, as seen in vNMRj 




5.3 Saturated Single Pulse (SATSP) 
 
 
Fig 14 SATSP pulse program, as seen in vNMRj 
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5.4 Chemical Shift Imaging (CSI) 
 
Fig 15 CSI pulse program, as seen in vNMRj 
Fig 16 CSI map and relative anatomical representation. Each voxel represented on the figure (PPA phantom 
SCOUT acquired  image) on the left has a correspondent spectrum on the right, creating a metabolic matrix. 






5.5 Gradient Echo (GEMS) 
 
Fig 17 GEMS pulse program, as seen in vNMRj 
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6. Experimental Protocols 
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7.  Methods of Data Analysis 
7.1 Preparation 
Fig 18 General view of jMRUI. A CSI sequence is displayed, where we can see the anatomical image and 
the selected voxel, the correspondent spectrum as well as a Phase Parameters toolbox 





Fig 19 Apodization Toolbox and its effect on the visual representation of a spectrum. No apodization was 
used on the left spectrum, as evidenced by the apparently erratic variations, and extreme apodization was 
used on the spectrum on the left, now displaying very smooth lines 
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Fig 22 Effect of zero filling on spectral resolution. The triplet resonance Beta-atp is not well resolved after 
a FT of the acquired data points. Zero filling the original data (by a power of 2), completely resolves the 
triplet resonance. After four times zero filling no further improvement in spectral resolution is observed 









Fig 23 A three way view of the AMARES toolbox as presented in jMRUI, displaying the three main parameter 
categories at our disposal, “Starting Values”, Prior Knowledge” and “Overall Phases”, from left to right 
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Prior Knowledge Phases Details 






































Table 2 Typical values/settings used in each of the AMARES required parameters  
 
 
Fig 24 Example of good data fitting using Amares. Estimated spectrum looks similar to the original one. 
 
Fig 25 Example of bad data fitting using Amares. Estimated spectrum barely resembles the original. 
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8. Phantom Design 
 
8.1 Liver Phantom 
 
8.1.1 Concept and early draft 
 
 
Fig 26 Early draft of the Liver Phantom. On the left, a sideway cut of both compartments and the surface 
coil on top. On the right, isometric perspective of the Liver Phantom with the surface coil on top. 
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8.1.2 Phantom Design and Production 
 
 
Fig 27 First tridimensional draft of the Liver Phantom. Both compartments are already in place, design is 
not final 




Fig 28 Left: Tridimensional model of the Liver Phantom. The two compartments are depicted in different 
colors for an easier interpretation. Right: Final, printed version of the Liver Phantom. The two pink 
duplicates are complete. The black phantom is missing its front side, making it possible to see the two 
separate compartments. 




Fig 29 Three-way perspective of the separated small mpartment, after the epoxy resin had been applied. 
 




Fig 30 Three-way view of the combined large and small compartment. 
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8.1.3 Phosphorous Components 
a. Small Compartment (Disodium phosphate) 
 
 




Molar mass 141.96 g/mol 
Appearance White crystalline solid 
Odor Odorless 
Density 1.7 g/cm3 
Melting point 250 °C 
Solubility in 
water 
7.7 g/100 ml (20 ºC) 
Acidity (pKa) 6.83 
Fig 31 Final, developed form of the Liver Phantom, next to and positioned inside the small 
protective plastic container. The container’s cap was itself wrapped in parafilm to supplementary 
prevent any leaks. 









Molar mass 158.09 g/mol 
Appearance Beige crystalline solid 
Odor Odorless 
Density 1.422 g/cm3 




Acidity (pKa) 1.85 
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Fig 32 SCOUT images of a transversal cut of the Liver Phantom with (right) and without 
(left) the air bubble (absence of signal in the small compartment), 
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8.2 PPA Phantom 
 
 
Fig 33 PPA Phantom in three different perspectives. 
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8.2.1 Phosphorous Components 
 




Fig 34 Threeway view of the FlipMap Phantom. 
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Molar mass 119.98 g/mol 
Appearance White powder or crystals 
Odor odorless 
Density 2.36 g/cm3 
Melting point 240 °C 
Solubility in 
water 
59.9 g/100 mL (0°C) 
Acidity (pKa) 4.52 
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Fig 35 ISIS pulse sequence | TR 2000 ms | 256 averages | 25x43x5 mm voxel, positioned inside the second 




Fig 36 ISIS pulse sequence | TR 2000 ms | 256 averages | 25x43x5 mm voxel, positioned inside the second 
compartment | EP [Hard, 135°, 50 µs, 45 dB] | IP [HS-AFP, 270°, 500 µs, 45dB] 





Fig 37 SPULS sequence with a low flip angle, Hard pulse 90° [100 µs, 35 dB] | 16 averages | TR 2000ms |  
 
 
Fig 38 SPULS sequence high flip angle, Hard pulse 350° [100 µs, 44 dB] | 16 averages | TR 2000ms | 
 






Fig 39 SATSP sequence | EP Hard 350° [100 µs, 45 dB] | SatP hs20 90° [2000 µs, 33dB] | 16 averages | TR 
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Fig 41 SATSP sequence | EP, Hard 350° [100 µs, 45 dB] | SatP, gauss 90° [2000 µs, 20dB] | 16 averages | 







Fig 42 SATSP sequence | EP, Hard 350° [100 µs, 45 dB] | SatP, Hard 360° [110 µs, 44dB] | 16 averages | TR 
2000ms | 
 56 | A  3 1 P  M R  S p e c t r o s c o p y  S t u d y  o n  R a t  M o d e l s  o f  L i v e r  D i s e a s e  
 
9.4 Chemical Shift Imaging  
Fig 43 CSI sequence  |2 dummy scans | 32 averages | TR 2000ms | Data Matrix 8x8 |Slice orientation – 
Coronal, Phase 1d 40mm, 2d 40mm, Thickness 40mm |No saturation bands were used 
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9.5 Phantom Data Analysis 




Fig 44 Metabolite Ratio varying on applied Flip Angle 
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Control Group [n1] 
 
Fig 49 ISIS pulse sequence | TR 2000 ms | 256 averages | 25x31x5 mm voxel, positioned inside the liver | 
EP [Hard, 200°, 100 µs, 44 dB] | IP [HS-AFP, 260°, 500 µs, 46dB] 
  












Fig 51 Control Group - subject n1| high flip angle 350° [EP [280 µs, 39dB] | 64 averages | SW 8000 Hz | 
SP [360° Hard, 140 µs, 45dB] 
Fig 50 Control Group - subject n1| high flip angle 350° [EP [280 µs, 39dB] | 64 averages | SW 8000 Hz |  
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Fig 52 Control Group - subject n2| high flip angle 350° [EP [280 µs, 39dB] | 64 averages | SW 8000 Hz |  
Fig 53 Control Group - subject n2| high flip angle 350° [EP [280 µs, 39dB] | 64 averages | SW 8000 
Hz | SP [360° Hard, 140 µs, 45dB] 
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10.3 Chemical Shift Imaging  
 
 
Control Group [c1] 
Fig 54 Control Group - subject n1 | CSI sequence |2 dummy scans | 64 averages | TR 2000ms | Data Matrix 8x8 
|Slice - Phase 1d 60mm, 2d 60mm, Thickness 10mm |No saturation bands were used 
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Control Group [c2] 
Fig 55 Control Group - subject n2 | CSI sequence |2 dummy scans | 64 averages | TR 2000ms | Data 
Matrix 8x8 |Slice - Phase 1d 60mm, 2d 60mm, Thickness 10mm |No saturation bands were used 
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Disease Model [dm1] 
Fig 56 Disease Model group  - subject DM1 | CSI sequence |2 dummy scans | 96 averages | TR 2000ms | 
Data Matrix 8x8 |Slice - Phase 1d 60mm, 2d 60mm, Thickness 15mm |No saturation bands were used 
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Disease Model [dm2] 
Fig 57 Disease Model group  - subject DM1 | CSI sequence |2 dummy scans | 96 averages | TR 2000ms | 
Data Matrix 8x8 |Slice - Phase 1d 60mm, 2d 60mm, Thickness 15mm |No saturation bands were used 
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10.4 In Vivo Data Analysis 
58]
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11. Additional Results 
11.1 Absolute Quantification 
Fig 58 Red squares depicts voxels with higher total combined acquired signal, while blue (all the way to 
translucent blue) squares represents those with lower acquired signal. 




Fig 59 PPA Phantom Voxel label for absolute quantification. 
α β γ
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Voxel Amplitude C   Voxel Amplitude C      Voxel Amplitude C 
[5,3] 1911 
50 
  [5,4] 2176 
50 
     [5,5] 2186 
50 [4,3] 2023   [4,4] 2452      [4,5] 2571 
[3,3] 1375   [3,4] 1767      [3,5] 1945 
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel    
PME 
Voxel      
PME 
Voxel  
[5,3] 3.3    [5,4] 12.2      [5,5] 10.9  
[4,3] 11.8    [4,4] 9.4      [4,5] 18.9  
[3,3] 21.3    [3,4] 22.6      [3,5] 19.9  
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel   
PDE 
Voxel      
PDE 
Voxel  
[5,3] 2.8   [5,4] 4.0      [5,5] 6.2  
[4,3] 3.9   [4,4] 4.1      [4,5] 5.1  
[3,3] 6.3   [3,4] 8.8      [3,5] 6.4  
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel   
PCr 
Voxel      
PCr 
Voxel  
[5,3] 29.0   [5,4] 26.1      [5,5] 15.7  
[4,3] 21.2   [4,4] 16.8      [4,5] 10.4  
[3,3] 9.6   [3,4] 5.3      [3,5] 2.2  
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel   
γ-ATP 
Voxel      
γ-ATP 
Voxel  
[5,3] 12.1   [5,4] 13.6      [5,5] 13.9  
[4,3] 11.8   [4,4] 12.7      [4,5] 11.5  
[3,3] 10.6   [3,4] 8.5      [3,5] 8.3  
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel   
α-ATP 
Voxel      
α-ATP 
Voxel  
[5,3] 16.1   [5,4] 19.9      [5,5] 19.8  
[4,3] 16.6   [4,4] 19.6      [4,5] 18.7  
[3,3] 22.8   [3,4] 16.1      [3,5] 13.9  
                 
  Adjusted 
C 
    Adjusted 
C 




Voxel   
β-ATP 
Voxel      
β-ATP 
Voxel  
[5,3] 13.3   [5,4] 15.5      [5,5] 16.0  
[4,3] 11.5   [4,4] 12.6      [4,5] 12.5  
[3,3] 11.1   [3,4] 7.9      [3,5] 8.7  
Table 6 Subject DM2 absolute metabolite concentration for each of the 9 considered voxels. 
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11.1.1 Discussion 
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𝐶𝑙𝑜𝑎𝑑 =  
𝑆𝑖𝑛 𝑣𝑖𝑡𝑟𝑜
𝑆𝑖𝑛 𝑣𝑖𝑣𝑜
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11.2 B1 Mapping 
 
11.2.1 Experimental Setup 
 










20 32 10 








Table 7 Parameters used in several GEMS image acquisitions. 
 






11.2.3 B1 Map creation (Matlab Script) 
 
%% Both images, acquired with different flip angles, are 
%% loaded and converted into doubles. A Flip Angle matrix 
%% (FA) is defined, having the same size as the previously 
%% loaded images. This FA matrix will later carry a flip 
%% angle value for each pixel. doublei40 matrix is created 
%% as the supposed multiple of matrix i20. 
Fig 60 Three FlipMap phantom gradient echo images acquired with different number 
of averages. From left to right, images were acquired with 32, 512 and 1024 averages, 
respectively. 
Fig 61 Three FlipMap phantom gradient echo images acquired with different flip angles. 
From left to right, images were acquired with 20, 40 and 80 degrees, respectively. 
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i40 = imread('NaP 1024av 40deg.jpg'); 
i80 = imread('NaP 1024av 80deg.jpg'); 
i40 = double(i40); 
i80 = double(i80); 
 
FA = zeros(128,128); 
doublei40 = 2*i40; 
 
%% A threshold (T) is set for the signal magnitude, below 
%% which a specific pixel is considered to be noise.   
 
T = 45; 
 
for i = 1:1:128; 
    for j =1:1:128; 
         
        if  doublei40(i,j) < T 
          doublei40(i,j) = 1; 
        end 
         
        if  i80(i,j) < T 
          i40(i,j) = 1; 
        end 
         
        FA(i,j) = acosd(i80(i,j)/doublei40(i,j)); 
    end 
end 
 
%% New matrix FAR (Flip Angle Real) cuts out the imaginary 
%% part of the FA matrix. Then, a noise reducing mechanism 
%% is applied. 
 
FAR = real(FA); 
 
for i = 1:1:128; 
    for j =1:1:128; 
        if  FAR(i,j) > 80 
          FAR(i,j) = 1; 
        end 




For the code to work as intended, the position of the phantom/subject must be 
kept exactly the same in relation to the coil, as the algorithm assumes that the 
position of each pixel is the same for both acquired images. 
 
11.2.4 Generated B1 maps 
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Fig 62 Generated B1 map without the noise correction algorithm 
 
Fig 63 Generated B1 map with the noise correction algorithm. 
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12. General Discussion 
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13. Conclusion 




14.1 SATSP pulse sequence 
  1  #ifndef LINT 
  2  static char SCCSid[] = "modified SPULS/PRESS with saturation bands"; 
  3  #endif 
  4  /* 
  5   * Varian,Inc. All Rights Reserved. 
  6   * This software contains proprietary and confidential 
  7   * information of Varian, Inc. and its contributors. 
  8   * Use, disclosure and reproduction is prohibited without 
  9   * prior consent. 
 10   */ 
 11  /****************************************************************** 
 12    SPULS + Saturation Slices 
 13   
 14  ******************************************************************/ 
 15   
 16  #include <standard.h> 
 17  #include "sgl.c" 
 18   
 19   
 20  pulsesequence() 
 21  { 
 22    /***** Internal variable declarations *****/ 
 23    double te_d1,te_d2,te_d3;             /* delays */ 
 24    double tr_delay; 
 25    double freq1,freq2,freq3; 
 26    char    volumercv[MAXSTR]; 
 27   
 28   
 29    get_parameters(); 
 30    get_ovsparameters(); 
 31   
 32    initparms_sis();  /* initialize standard imaging parameters */ 
 33   
 34    getstr("volumercv",volumercv); 
 35   
 36    te2 = getvalnwarn("te2"); 
 37   
 38    /***** RF power calculations *****/ 
 39    init_rf(&p1_rf,p1pat,p1,flip1,rof1,rof2); 
 40    init_rf(&p2_rf,p2pat,p2,flip2,rof1,rof2); 
 41    calc_rf(&p1_rf,"tpwr1","tpwr1f"); 
 42    calc_rf(&p2_rf,"tpwr2","tpwr2f"); 
 43   
 44    /***** Initialize gradient structs *****/ 
 45    init_slice(&vox1_grad,"vox1",vox1); 
 46    init_slice_refocus(&vox1r_grad,"vox1r"); 
 47   
 48    /***** Gradient calculations *****/ 
 49    calc_slice(&vox1_grad,&p1_rf,WRITE,"gvox1"); 
 50    calc_slice_refocus(&vox1r_grad,&vox1_grad,WRITE,"gvox1r"); 
 51   
 52    if (vox1_grad.rfDelayFront < 0.2e-6) vox1_grad.rfDelayFront = 0; 
 53    if (vox1_grad.rfDelayBack  < 0.2e-6) vox1_grad.rfDelayBack  = 0; 
 54   
 55   
 56    /* Optional Outer Volume Suppression and Saturation Bands */ 
 57    if (ovs[0] == 'y')  create_ovsbands(); 
 58    if (sat[0] == 'y')  create_satbands(); 
 59   
 60    /***** Min TR *****/ 
 61    trmin = 4e-6 + at; 
 62   
 63    if (ovs[0] == 'y') trmin += ovsTime; 
 64    if (sat[0] == 'y') trmin += satTime; 
 65   
 66    if (mintr[0] == 'y') { 
 67      tr = trmin+4e-6;  // ensure at least 4us between gradient events 
 68      putvalue("tr",tr); 
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 69    } 
 70    if (tr < trmin+4e-6) { 
 71      abort_message("tr too short. Minimum tr = %.2f ms\n",(trmin+4e-6)*1000); 
 72    } 
 73   
 74    /***** Calculate TR delay *****/ 
 75    tr_delay = tr - trmin; 
 76   
 77   
 78    /* Frequency offsets */ 
 79    freq1    = poffset(pos1,vox1_grad.ssamp); // First  RF pulse 
 80    roff     = resto-tof;   // receiver frequency, delta from transmitter 
 81    tof=5500; 
 82   
 83   
 84    /* Put gradient information back into VnmrJ parameters */ 
 85    putvalue("gvox1",vox1_grad.ssamp); 
 86   
 87    putvalue("rgvox1",vox1_grad.tramp); 
 88   
 89    putvalue("tvox1",vox1r_grad.duration); 
 90    putvalue("rgvox1r",vox1r_grad.tramp); 
 91   
 92   
 93    sgl_error_check(sglerror); 
 94   
 95   
 96    /* Relaxation delay ***********************************/ 
 97    status(A); 
 98    obsoffset(resto); 
 99    delay(4e-6); 
100    rot_angle(vpsi,vphi,vtheta); 
101    xgate(ticks); 
102   
103    if (ix == 1) grad_advance(tep); 
104   
105    /* Saturation bands ***********************************/ 
106    if (ovs[0] == 'y') ovsbands(); 
107    if (sat[0] == 'y') satbands(); 
108    delay(4e-6); 
109   
110    /* Slice selective 90 degree RF pulse *****/ 
111   
112    obspower(tpwr); 
113   
114     shapedpulse(pwpat,pw,oph,rof1,rof2); 
115   
116     startacq(alfa); 
117     acquire(np,(1.0/sw)); 
118     endacq(); 
119   
120    delay(tr_delay); 
121   
122  } 
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14.2 Flip Angle map generation in matlab 
 1  /* Matlab code for B1 map generation (example) */ 
 2   
 3  i40 = imread('NaP 1024av 40deg.jpg'); 
 4  i80 = imread('NaP 1024av 80deg.jpg'); 
 5  i40 = double(i40); 
 6  i80 = double(i80); 
 7   
 8  FA = zeros(128,128); 
 9  T = 45; 
10   
11  ii40 = 2*i40; 
12   
13  for i = 1:1:128; 
14      for j =1:1:128; 
15   
16          if  ii40(i,j) < T 
17            ii40(i,j) = 1; 
18          end 
19   
20          if  i80(i,j) < T 
21            i80(i,j) = 1; 
22          end 
23   
24          FA(i,j) = acosd(i80(i,j)/ii40(i,j)); 
25      end 
26  end 
27   
28  FAR = real(FA); 
29  for i = 1:1:128; 
30      for j =1:1:128; 
31          if  FAR(i,j) > 80 
32            FAR(i,j) = 1; 
33          end 
34      end 
35  end 
36   










P. Rossi, P. Ricci, and L. Broglia, Portal Hypertension: Diagnostic Imaging and Imaging-guided Therapy ; with 49 Tables. Springer 
Science & Business Media, 2000. 
[2] 
R. N. Anderson and B. L. Smith, “Deaths: leading causes for 2001,”Natl Vital Stat Rep, vol. 52, no. 9, pp. 1–85, Nov. 2003. 
[3] 
L. Castéra, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, M. Haaser, M. Darriet, P. Couzigou, and V. De Lédinghen, “Prospective 
comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis 
C,”Gastroenterology, vol. 128, no. 2, pp. 343–350, Feb. 2005. 
[4] 
I. R. Corbin, R. Buist, J. Peeling, M. Zhang, J. Uhanova, and G. Y. Minuk, “Hepatic 31P MRS in rat models of chronic liver disease: 
assessing the extent and progression of disease,” Gut, vol. 52, no. 7, pp. 1046–1053, Jul. 2003. 
[5] 
M. Ronot, S. A. Lambert, M. Wagner, P. Garteiser, S. Doblas, M. Albuquerque, V. Paradis, V. Vilgrain, R. Sinkus, and B. E. Van Beers, 
“Viscoelastic Parameters for Quantifying Liver Fibrosis: Three-Dimensional Multifrequency MR Elastography Study on Thin Liver Rat 
Slices,” PLoS ONE, vol. 9, no. 4, p. e94679, Apr. 2014. 
 [6] 
H. J. Alter, Y. Nakatsuji, J. Melpolder, J. Wages, R. Wesley, J. W. Shih, and J. P. Kim, “The incidence of transfusion-associated hepatitis 
G virus infection and its relation to liver disease,” N. Engl. J. Med., vol. 336, no. 11, pp. 747–754, Mar. 1997. 
 [7] 
K. K. Changani, B. J. Fuller, D. J. Bryant, J. D. Bell, M. Ala-Korpela, S. D. Taylor-Robinson, D. P. Moore, and B. R. Davidson, “Non-
invasive assessment of ATP regeneration potential of the preserved donor liver. A 31P MRS study in pig liver,” J. Hepatol., vol. 26, 
no. 2, pp. 336–342, Feb. 1997. 
 [8] 
E. M. Haacke, R. W. Brown, M. R. Thompson, and R. Venkatesan,Magnetic Resonance Imaging: Physical Principles and Sequence 
Design, 1st edition. New York: Wiley-Liss, 1999. 
 [9] 
C. Westbrook, C. K. Roth, and J. Talbot, MRI in Practice, 4th Edition edition. Chichester, West Sussex ; Malden, MA: Wiley-Blackwell, 
2011. 
 [10] 
M. A. Flower, Webb’s Physics of Medical Imaging, Second Edition. CRC Press, 2012. 
[11] 
V. Kuperman, Magnetic Resonance Imaging: Physical Principles and Applications. Academic Press, 2000. 
[12] 
J. C. Maxwell and F. Jenkin, “LXI. On the elementary relations between electrical measurements,” Philosophical Magazine Series 4, 
vol. 29, no. 198, pp. 436–460, Jun. 1865. 
[13] 
F. Bloch, R. I. Condit, and H. H. Staub, “Neutron Polarization and Ferromagnetic Saturation,” Phys. Rev., vol. 70, no. 11–12, pp. 972–
973, Dec. 1946. 
[14] 
R. A. de Graaf, In Vivo NMR Spectroscopy: Principles and Techniques, 2nd Edition edition. Chichester, West Sussex, England ; 
Hoboken, NJ: Wiley-Blackwell, 2007. 
[15]  
Lebon V, Petersen KF, Cline GW, Shen J, Mason GF, Dufour S, Behar KL, Shulman GI, Rothman DL. Astroglial contribution to brain 
energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for 
neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 22, 1523–1531 (2002). 
[16]  




Blakely RD, Coyle JT. The neurobiology of N-acetylaspartylglutamate. Int Rev Neurobiol 30, 39–100 (1988). 
 
[18] 
H. Van As and D. van Dusschoten, “NMR methods for imaging of transport processes in micro-porous systems,” Geoderma, vol. 80, 
no. 3–4, pp. 389–403, Nov. 1997. 
 90 | A  3 1 P  M R  S p e c t r o s c o p y  S t u d y  o n  R a t  M o d e l s  o f  L i v e r  D i s e a s e  
 
[19] 
G. R. Morrell, “A phase-sensitive method of flip angle mapping,” Magn. Reson. Med., vol. 60, no. 4, pp. 889–894, Oct. 2008. 
[20] 
C. H. Cunningham, K. S. Nayak, and J. M. Pauly, “RF field mapping for magnetic resonance imaging,” US7446526 B2, 04-Nov-2008. 
[21] 
L. I. Sacolick, F. Wiesinger, I. Hancu, and M. W. Vogel, “B1 Mapping by Bloch-Siegert Shift,” Magn Reson Med, vol. 63, no. 5, pp. 
1315–1322, May 2010. 
[22] 
R. Stollberger and P. Wach, “Imaging of the active B1 field in vivo,”Magn. Reson. Med., vol. 35, no. 2, pp. 246–251, Feb. 1996. 
[23] 
R. Treier, A. Steingoetter, M. Fried, W. Schwizer, and P. Boesiger, “Optimized and combined T1 and B1 mapping technique for fast 
and accurate T1 quantification in contrast-enhanced abdominal MRI,” Magn. Reson. Med., vol. 57, no. 3, pp. 568–576, Mar. 2007. 
[24] 
“Section 5.5: Spin-spin coupling,” chemwiki.ucdavis.edu. [Online]. Available: 
http://chemwiki.ucdavis.edu/Organic_Chemistry/Organic_Chemistry_With_a_Biological_Emphasis/Chapter_05%3A_Structure_De
termination_II/Section_5.5%3A_Spin-spin_coupling. [Accessed: 11-Oct-2014]. 
[25] 
R. Issa, X. Zhou, N. Trim, H. Millward-Sadler, S. Krane, C. Benyon, and J. Iredale, “Mutation in collagen-1 that confers resistance to 
the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, 
and diminished hepatocyte regeneration,” FASEB J, vol. 17, no. 1, pp. 47–49, 2003. 
[26] 
J. P. Iredale, “Hepatic Stellate Cell Behavior during Resolution of Liver Injury,” Seminars in Liver Disease, vol. 21, no. 03, pp. 427–436, 
2001. 
[27] 
F. Ursini, M. Maiorino, M. Valente, L. Ferri, and C. Gregolin, “Purification from pig liver of a protein which protects liposomes and 
biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine 
hydroperoxides,” Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 710, no. 2, pp. 197–211, Feb. 1982. 
 [28] 
Y. Kamada, S. Tamura, S. Kiso, H. Matsumoto, Y. Saji, Y. Yoshida, K. Fukui, N. Maeda, H. Nishizawa, H. Nagaretani, Y. Okamoto, S. 
Kihara, J. Miyagawa, Y. Shinomura, T. Funahashi, and Y. Matsuzawa, “Enhanced carbon tetrachloride-induced liver fibrosis in mice 
lacking adiponectin,” Gastroenterology, vol. 125, no. 6, pp. 1796–1807, Dec. 2003. 
[29] 
G. Vendemiale, I. Grattagliano, M. L. Caruso, G. Serviddio, A. M. Valentini, M. Pirrelli, and E. Altomare, “Increased Oxidative Stress 
in Dimethylnitrosamine-Induced Liver Fibrosis in the Rat: Effect of N-Acetylcysteine and Interferon-α,” Toxicology and Applied 
Pharmacology, vol. 175, no. 2, pp. 130–139, Sep. 2001. 
[30] 
“Systemic Infusion of FLK1+ Mesenchymal Stem Cells Ameliorate... : Transplantation.” [Online]. 
Available:http://journals.lww.com/transplantjournal/Fulltext/2004/07150/Systemic_Infusion_of_FLK1__Mesenchymal_Stem_Cell
s.14.aspx. [Accessed: 11-Oct-2014]. 
[31] 
C. Constandinou, N. Henderson, and J. P. Iredale, “Modeling Liver Fibrosis in Rodents,” in Fibrosis Research, J. Varga, D. A. Brenner, 
and S. H. Phan, Eds. Totowa, NJ: Humana Press, 2005, pp. 237–250. 
[32] 
A. Canbay, S. Friedman, and G. J. Gores, “Apoptosis: The nexus of liver injury and fibrosis,” Hepatology, vol. 39, no. 2, pp. 273–278, 
Feb. 2004. 
[33] 
P. Hammel, A. Couvelard, D. O’Toole, A. Ratouis, A. Sauvanet, J. F. Fléjou, C. Degott, J. Belghiti, P. Bernades, D. Valla, P. Ruszniewski, 
and P. Lévy, “Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common 
Bile Duct,” New England Journal of Medicine, vol. 344, no. 6, pp. 418–423, Feb. 2001. 
[34] 
P. de la M Hall, C. S. Lieber, L. M. DeCarli, S. W. French, K. O. Lindros, H. Järveläinen, C. Bode, A. Parlesak, and J. C. Bode, “Models of 




P. P. Simeonova, R. M. Gallucci, T. Hulderman, R. Wilson, C. Kommineni, M. Rao, and M. I. Luster, “The Role of Tumor Necrosis 
Factor-α in Liver Toxicity, Inflammation, and Fibrosis Induced by Carbon Tetrachloride,” Toxicology and Applied Pharmacology, vol. 
177, no. 2, pp. 112–120, Dec. 2001. 
 91 | A  3 1 P  M R  S p e c t r o s c o p y  S t u d y  o n  R a t  M o d e l s  o f  L i v e r  D i s e a s e  
 
[36] 
S. Sawada, K. Murakami, J. Murata, K. Tsukada, and I. Saiki, “Accumulation of extracellular matrix in the liver induces high metastatic 
potential of hepatocellular carcinoma to the lung,” International Journal of Oncology, vol. 19, no. 1, pp. 65–70, Jul. 2001. 
[37] 
J. A. Fallowfield and J. P. Iredale, “Targeted treatments for cirrhosis,”Expert Opin. Ther. Targets, vol. 8, no. 5, pp. 423–435, Oct. 2004. 
[38] 
Y. N. Kallis, A. J. Robson, J. A. Fallowfield, H. C. Thomas, M. R. Alison, N. A. Wright, R. D. Goldin, J. P. Iredale, and S. J. Forbes, 
“Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response,” Gut, vol. 60, no. 4, pp. 525–533, 2011. 
[39] 
J. A. Fallowfield, “Therapeutic targets in liver fibrosis,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 300, 
no. 5, pp. G709–G715, May 2011. 
[40] 
A. Pellicoro, P. Ramachandran, J. P. Iredale, and J. A. Fallowfield, “Liver fibrosis and repair: immune regulation of wound healing in a 
solid organ,” Nat Rev Immunol, vol. 14, no. 3, pp. 181–194, Mar. 2014. 
[41] 
“Laboratory rat,” Wikipedia, the free encyclopedia. 11-Oct-2014. 
 
[42] 
O. D. Bengt Noren, “Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance 
spectroscopy” European journal of radiology, vol. 66, no. 2, pp. 313–20, 2008. 
 
[43] 
J. D. Bell, I. J. Cox, J. Sargentoni, C. J. Peden, D. K. Menon, C. S. Foster, P. Watanapa, R. A. Iles, and J. Urenjak, “A 31P and 1H-NMR 
investigation in vitro of normal and abnormal human liver,” Biochim. Biophys. Acta, vol. 1225, no. 1, pp. 71–77, Nov. 1993. 
 
[44] 
A. Kumar and P. A. Bottomley, “Optimized quadrature surface coil designs,” MAGMA, vol. 21, no. 1–2, pp. 41–52, Mar. 2008. 
 
[45] 
R. J. Ordidge, A. Connelly, and J. A. B. Lohman, “Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective 
nmr spectroscopy,” Journal of Magnetic Resonance (1969), vol. 66, no. 2, pp. 283–294, Feb. 1986. 
 
[46] 
S. S. Rajan, “MRI Hardware System Components,” in MRI, Springer New York, 1998, pp. 25–39. 
 
[47] 
J. P. Hannon, “Effect of Temperature on the Heart Rate, Electrocardiogram and Certain Myocardial Oxidations of the Rat,”Circulation 
Research, vol. 6, no. 6, pp. 771–778, 1958. 
 
[48] 




Vanhamme, van den Boogaart A, and Van Huffel S, “Improved method for accurate and efficient quantification of MRS data with 
use of prior knowledge,” J. Magn. Reson., vol. 129, no. 1, pp. 35–43, Nov. 1997. 
 
[50] 
J. Weis, L. Johansson, F. Ortiz-Nieto, and H. Ahlström, “Assessment of lipids in skeletal muscle by LCModel and AMARES,” J Magn 
Reson Imaging, vol. 30, no. 5, pp. 1124–1129, Nov. 2009. 
 
[51] 
D. E. Bohning, A. C. Wright, and K. M. Spicer, “In vivo phosphorus spectroscopy of human skin,” Magn. Reson. Med., vol. 35, no. 2, 
pp. 186–193, Feb. 1996. 
 
[52] 
“Plastic Properties of Acrylonitrile Butadiene Styrene (ABS),” www.dynalabcorp.com [Online]. Available: 
http://www.dynalabcorp.com/technical_info_abs.asp. [Accessed: 11-Oct-2014]. 
[53] 
“Chemical Database” www.chemspider.com [Online] 
 
[54] 
C. J. Cooksey, E. J. Land, and P. A. Riley, “A SIMPLE ONE-POT PREPARATION OF 4-ALKOXY-AND 4-ALKYLTHIO-CATECHOLS AND o -
BENZOQUINONES,” Organic Preparations and Procedures International, vol. 28, no. 4, pp. 463–467, Aug. 1996. 
 
 92 | A  3 1 P  M R  S p e c t r o s c o p y  S t u d y  o n  R a t  M o d e l s  o f  L i v e r  D i s e a s e  
 
[55] 
K. Schrödter, G. Bettermann, T. Staffel, F. Wahl, T. Klein, and T. Hofmann, “Phosphoric Acid and Phosphates,” in Ullmann’s 
Encyclopedia of Industrial Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA, 2000. 
 
[56] 
S. Fortune, M. A. Jansen, T. Anderson, G. A. Gray, J. E. Schneider, P. R. Hoskins, and I. Marshall, “Development and characterization 




G. A. Webb, Modern Magnetic Resonance: Part 1: Applications in Chemistry, Biological and Marine Sciences, Part 2: Applications in 








B. Norén, P. Lundberg, M. Ressner, S. Wirell, S. Almer, and O. Smedby, “Absolute quantification of human liver metabolite 
concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease,” Eur Radiol, vol. 15, no. 1, pp. 148–157, Jan. 2005. 
 
 
 
 
 
